We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current LUMO market cap is 37.54M. The company's latest EPS is USD -3.9352 and P/E is -0.23.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 7k | 826k | 165k | 488k | 726k |
| Operating Income | -8.93M | -10M | -10.86M | -7.82M | -7.64M |
| Net Income | -8.3M | -9.46M | -10.44M | -7.55M | -7.47M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 936k | 168k | 230k | 1.52M | 2.05M |
| Operating Income | -45.13M | -26.3M | -31.35M | -32.04M | -36.61M |
| Net Income | -42.99M | -5.66M | -30.43M | -31.06M | -34.03M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 47.75M | 40.64M | 28.08M | 21.36M | 17.46M |
| Total Liabilities | 12.26M | 13.33M | 10.64M | 11.08M | 12.55M |
| Total Equity | 35.49M | 27.31M | 17.44M | 10.28M | 4.91M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 96.79M | 129.03M | 100.31M | 72.29M | 40.64M |
| Total Liabilities | 17.91M | 12.46M | 11.34M | 12.71M | 13.33M |
| Total Equity | 78.88M | 116.57M | 88.98M | 59.58M | 27.31M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -23.7M | -31.1M | -12.89M | -19.27M | -24.28M |
| Investing | 4.57M | 10.74M | 1M | 1M | 1M |
| Financing | -1.32M | -576k | -5k | -5k | 1.72M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -30.21M | -23M | -29.65M | -26.62M | -31.1M |
| Investing | 77k | 116.65M | 25.97M | -11.36M | 10.74M |
| Financing | -59k | 75k | -192k | -821k | -576k |
| Market Cap | 37.54M |
| Price to Earnings Ratio | -0.23 |
| Price to Sales Ratio | 3.75 |
| Price to Cash Ratio | 0.22 |
| Price to Book Ratio | 0.28 |
| Dividend Yield | - |
| Shares Outstanding | 8.65M |
| Average Volume (1 week) | 182.33k |
| Average Volume (1 Month) | 134.73k |
| 52 Week Change | 53.36% |
| 52 Week High | 4.5756 |
| 52 Week Low | 1.3701 |
| Spread (Intraday) | -0.12 (-2.86%) |
| Company Name | Lumos Pharma Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://lumos-pharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
